Indefinite Delivery Contract HHSO100201700014I

This is a multiple award indefinite delivery contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to conduct safety evaluation and toxicology studies to support drug development. The $48.6 million contract has a 6-year ordering period from June 2024 to June 2030. The contractor, IIT Research Institute (IITRI), a non-profit research organization, will perform in vitro and in vivo exploratory and...

The key products and services being delivered under this federal contract IDV award from the National Cancer Institute (NCI) are preclinical toxicology studies on small molecule drug candidates for cancer and other indications. The prime contractor, IIT Research Institute (IITRI), a division of the Illinois Institute of Technology, will conduct non-GLP and GLP toxicology assessments in mice and dogs to support Investigational New Drug (IND) applications. IITRI holds several significant IDIQ...

This indefinite delivery contract (IDC) was awarded by a U.S. federal government agency to IIT Research Institute (IITRI), a non-profit contract research organization. The IDC is a multiple-award vehicle with a $0 ceiling value and an ultimate completion date of September 30, 2007. Under this IDC, IITRI provides a range of preclinical research services to support federal agencies such as the National Institutes of Health (NIH), including the National Cancer Institute (NCI), National Institute of...

The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded an indefinite delivery/indefinite quantity contract to IIT Research Institute of Chicago, Illinois with a potential value of $174,470,000. The contract aims to procure pharmacology and toxicology services to support the Pharmacology and Toxicology for Therapeutics Program. Services include non-GLP ADME/PK/TOX studies for up to 10 projects annually, GLP enabling toxicology studies for up to 5...

This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to IIT Research Institute (IITRI), a non-profit contract research organization. The contract, with a ceiling value of $0, is part of the Preclinical Agent Development Assays 2012-2016 program and supports preclinical in vitro and in vivo agent development assays. Under this IDC, IITRI provides a range of preclinical research...

This federal indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to the non-profit IIT Research Institute (IITRI). The $19 million PREVENT Toxicology and Pharmacology Testing (PREVENT TOX) IDIQ contract vehicle enables NCI to efficiently access IITRI's preclinical research capabilities on an as-needed basis to support the development of cancer prevention therapies. Task orders issued under this...

This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a subsidiary of the Illinois Institute of Technology. The contract has a ceiling value of $146.3 million and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with a range of preclinical research services related to the development and...

This Indefinite Delivery Contract is a parent IDIQ vehicle awarded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to Southern Research Institute, a non-profit research organization. The Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ has a total potential value of $174,470,000 and a period of performance through September 12, 2026. Under this IDIQ, Southern Research has been awarded multiple task orders to provide drug discovery,...

This indefinite delivery contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health within the Department of Health and Human Services, to IIT Research Institute (IITRI), a non-profit contract research organization. The $74,995,000 multiple-award contract, titled the "PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Biomarkers," supports preclinical efficacy and biomarker evaluation, manufacturing, and...

The federal contract IDV award provides indefinite delivery of nonclinical biological services to the Department of Health and Human Services (HHS), specifically the Office of the Assistant Secretary for Preparedness and Response (ASPR). The purpose is to establish a network of Good Laboratory Practices (GLP) facilities capable of conducting animal testing and other analytical services to support the development of medical countermeasures against chemical, biological, radiological, and nuclear...